Skip to main content
Premium Trial:

Request an Annual Quote

DeCode Identifies Schizophrenia Gene, Shares Jump

NEW YORK, Oct 20 – DeCode Genetics and Hoffman-La Roche said Friday DeCode had located a gene linked to schizophrenia, sending shares of the Icelandic company up more than seven percent on the Nasdaq.

DeCode scientists discovered the gene by working with psychiatrists from the Icelandic healthcare system to screen the genomes of 400 Icelandic schizophrenia patients as well as unaffected family members.

The scientists are now screening the gene for various mutations and plan to publish their findings within the next several months, DeCode spokesman Edward Farmer said. At present, DeCode will not reveal the chromosomal location of the gene or any specific information about its nature.

Roche, which began a five-year collaboration with DeCode in early 1998 to find genes for 12 common diseases, is already using the information from DeCode’s analysis to develop diagnostic tools and drugs for schizophrenia, Roche spokeswoman Katja Prowald said.

DeCode has received an undisclosed milestone payment from Roche for part of this accomplishment.

Roche is confident that these results will apply to the broader population affected by schizophrenia. “Our research has shown that the results from the studies done by DeCode are very representative and are not specific for the Icelandic population only,” said Prowald.

Shares of DeCode were up 1 5/16, or 7.3 percent, at 19 5/16 in afternoon trading.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.